Skip to main content

Contact Lens Wearer

0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
3 programs
All participants received Biotrue ONEday lenses with and without an alternate packaging solutionN/A1 trial
kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9DN/A1 trial
samfilcon A Lenses with EPG01 Packaging SolutionN/A1 trial
Active Trials
NCT05129488Completed33Est. Sep 2021
NCT05129072Completed75Est. Sep 2021
NCT05126953Completed30Est. Sep 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bausch Healthsamfilcon A Lenses with EPG01 Packaging Solution
Bausch HealthAll participants received Biotrue ONEday lenses with and without an alternate packaging solution
Bausch Healthkalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D

Clinical Trials (3)

Total enrollment: 138 patients across 3 trials

NCT05126953Bausch Healthsamfilcon A Lenses with EPG01 Packaging Solution

2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

Start: Sep 2021Est. completion: Sep 202130 patients
N/ACompleted
NCT05129488Bausch HealthAll participants received Biotrue ONEday lenses with and without an alternate packaging solution

Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact Lenses

Start: Sep 2021Est. completion: Sep 202133 patients
N/ACompleted
NCT05129072Bausch Healthkalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D

Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses

Start: Aug 2021Est. completion: Sep 202175 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.